Skip to content
Men Under Microscope – Lifestyle
Home
Sample Page
Author:
Femasys Inc.
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
April 1, 2026
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
April 1, 2026
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
March 18, 2026
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
March 10, 2026
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
March 10, 2026
←
Previous Page
1
2